Free Trial

Elite Pharmaceuticals (ELTP) Short Interest Ratio & Short Volume

Elite Pharmaceuticals logo
$0.51
+0.01 (+2.00%)
(As of 11/4/2024 ET)

Elite Pharmaceuticals Short Interest Data

Elite Pharmaceuticals (ELTP) has a short interest of 2.00 million shares. This marks a -1.57% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 5.15 million shares to cover all short positions.

Current Short Interest
2,004,100 shares
Previous Short Interest
2,036,000 shares
Change Vs. Previous Month
-1.57%
Dollar Volume Sold Short
$883,006.46
Short Interest Ratio
0.6 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
1,068,270,000 shares
Percentage of Shares Shorted
0.19%
Today's Trading Volume
1,454,023 shares
Average Trading Volume
5,152,222 shares
Today's Volume Vs. Average
28%
Short Selling Elite Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Elite Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ELTP Short Interest Over Time

ELTP Days to Cover Over Time

ELTP Percentage of Float Shorted Over Time

Elite Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/20242,004,100 shares $883,006.46 -1.6%N/A0.6 $0.44
9/30/20242,036,000 shares $789,968.00 -7.3%N/A0.6 $0.39
9/15/20242,195,500 shares $790,599.55 +19.7%N/A0.2 $0.36
8/31/20241,834,800 shares $507,597.42 +10.5%N/A0.3 $0.28
8/15/20241,661,100 shares $317,436.21 +5.0%N/A1 $0.19
7/31/20241,581,500 shares $294,159.00 -9.2%N/A1.4 $0.19
7/15/20241,740,800 shares $330,752.00 +7.1%N/A1 $0.19
6/30/20241,625,700 shares $323,514.30 +4.8%N/A1 $0.20
6/15/20241,550,800 shares $261,092.69 -2.4%N/A2.4 $0.17
5/31/20241,588,700 shares $274,845.10 +3.8%N/A1.3 $0.17
5/15/20241,530,700 shares $214,144.93 -4.1%N/A1.3 $0.14
4/30/20241,595,900 shares $207,147.82 -0.3%N/A1.8 $0.13
4/15/20241,601,300 shares $216,175.50 +2.9%N/A1.4 $0.14
3/31/20241,555,700 shares $240,106.74 -7.7%N/A1.4 $0.15
3/15/20241,684,700 shares $234,173.30 +5.1%N/A0.9 $0.14
2/29/20241,602,900 shares $258,066.90 +0.9%N/A0.4 $0.16
2/15/20241,588,800 shares $293,769.12 +75.2%N/A0.5 $0.18
1/15/2024103,200 shares $18,008.40 +24.8%N/A0 $0.17
12/31/202382,700 shares $11,578.00 No ChangeN/A0 $0.14
11/30/202380,600 shares $11,084.11 +58.4%N/A0 $0.14
11/15/202350,900 shares $7,380.50 No ChangeN/A0 $0.15
10/15/2023228,000 shares $21,831.00 +113.5%N/A0.3 $0.10
9/30/2023106,800 shares $10,019.44 +862.2%N/A0.1 $0.09
9/15/202311,100 shares $865.80 -94.8%N/A0 $0.08
8/31/2023211,700 shares $18,629.60 +1,283.7%N/A0 $0.09
8/15/202315,300 shares $711.45 -74.6%N/A0 $0.05
7/31/202360,300 shares $2,532.60 +102.4%N/A0 $0.04
7/15/202329,800 shares $1,132.40 No ChangeN/A0 $0.04
6/15/202311,000 shares $374.00 -7.6%N/A0 $0.03
5/31/202311,900 shares $367.71 +643.8%N/A0 $0.03
5/15/20231,600 shares $49.44 -85.7%N/A0 $0.03
4/30/202311,200 shares $369.60 +3,633.3%N/A0 $0.03
4/15/2023300 shares $9.30 -93.6%N/A0 $0.03
3/31/20234,700 shares $136.30 +193.8%N/A0 $0.03
3/15/20231,600 shares $50.40 -20.0%N/A0 $0.03
2/28/20232,000 shares $71.20 -95.5%N/A0 $0.04
2/15/202344,200 shares $1,701.70 +44.9%N/A0.1 $0.04
1/31/202330,500 shares $1,030.90 +74.3%N/A0 $0.03
1/15/202317,500 shares $525.00 +2,087.5%N/A0 $0.03
12/30/2022800 shares $23.60 +700.0%N/A0 $0.03
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

12/15/2022100 shares $3.00 -99.0%N/A0 $0.03
11/30/202210,000 shares $329.00 -54.3%N/A0 $0.03
11/15/202221,900 shares $755.55 +1,268.8%N/A0.1 $0.03
10/31/20221,600 shares $57.28 -96.3%N/A0 $0.04
10/15/202242,800 shares $1,326.80 No ChangeN/A0 $0.03
9/15/2022400 shares $14.40 -99.4%N/A0 $0.04
8/31/202269,300 shares $2,477.48 -2.8%N/A0 $0.04
8/15/202271,300 shares $3,208.50 No ChangeN/A0.1 $0.05
7/15/20221,000 shares $42.90 -83.1%N/A0 $0.04
6/30/20225,900 shares $295.00 No ChangeN/A0 $0.05
5/31/20222,700 shares $123.39 No ChangeN/A0 $0.05
4/15/202216,900 shares $611.44 No ChangeN/A0 $0.04
2/28/2022212,900 shares $8,516.00 +3,030.9%N/A0.2 $0.04
2/15/20226,800 shares $289.00 -89.5%N/A0 $0.04
1/31/202264,500 shares $2,547.75 No ChangeN/A0.1 $0.04
12/31/2021100 shares $3.31 No ChangeN/A0 $0.03
12/15/2021100 shares $3.70 -99.6%N/A0 $0.04
11/30/202124,600 shares $883.14 +24,500.0%N/A0 $0.04
11/15/2021100 shares $3.82 -98.9%N/A0 $0.04
10/29/20219,400 shares $362.84 -38.2%N/A0 $0.04
10/15/202115,200 shares $608.00 +280.0%N/A0 $0.04
9/30/20214,000 shares $172.00 No ChangeN/A0 $0.04
8/31/202111,500 shares $543.95 +8.5%N/A0 $0.05
8/13/202110,600 shares $484.42 -46.7%N/A0 $0.05
7/30/202119,900 shares $953.21 +74.6%N/A0 $0.05
7/15/202111,400 shares $550.62 No ChangeN/A0 $0.05
6/15/202112,200 shares $668.56 No ChangeN/A0 $0.05
5/14/202121,600 shares $1,252.80 +151.2%N/A0 $0.06
4/30/20218,600 shares $467.41 No ChangeN/A0 $0.05
3/31/20211,500 shares $87.00 -89.2%N/A0 $0.06
3/15/202113,900 shares $847.90 -65.6%N/A0 $0.06
2/26/202140,400 shares $2,585.60 +1,054.3%N/A0 $0.06
2/12/20213,500 shares $261.80 +218.2%N/A0 $0.07
1/29/20211,100 shares $64.35 -83.3%N/A0 $0.06
12/31/202012,500 shares $675.00 No ChangeN/A0 $0.05
11/30/202027,400 shares $1,479.60 -68.4%N/A0 $0.05
11/15/202086,700 shares $6,675.90 No ChangeN/A0.1 $0.08
10/15/202012,100 shares $847.00 No ChangeN/A0 $0.07
8/31/202073,800 shares $5,830.20 +939.4%N/A0 $0.08
8/14/20207,100 shares $477.83 -92.6%N/A0 $0.07
7/31/202096,500 shares $6,031.25 +222.7%N/A0.1 $0.06
7/15/202029,900 shares $2,299.31 +121.5%N/A0 $0.08
6/30/202013,500 shares $1,120.50 -59.0%N/A0 $0.08
6/15/202032,900 shares $2,961.00 No ChangeN/A0 $0.09
5/15/202022,200 shares $1,698.30 +27.6%N/A0 $0.08
4/30/202017,400 shares $1,392.00 No ChangeN/A0 $0.08
3/31/20209,600 shares $691.20 +3,100.0%N/A0 $0.07
3/13/2020300 shares $18.90 No ChangeN/A0 $0.06
2/28/2020300 shares $24.60 No ChangeN/A0 $0.08
2/14/2020300 shares $27.75 -99.7%N/A0 $0.09
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

1/31/202085,000 shares $8,670.00 +293.5%N/A0.1 $0.10
1/15/202021,600 shares $2,265.84 +7,100.0%N/A0 $0.10
12/31/2019300 shares $27.45 -98.7%N/A0 $0.09

ELTP Short Interest - Frequently Asked Questions

What is Elite Pharmaceuticals' current short interest?

Short interest is the volume of Elite Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 2,004,100 shares of ELTP short. Learn More on Elite Pharmaceuticals' current short interest.

What is a good short interest ratio for Elite Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELTP shares currently have a short interest ratio of 1.0. Learn More on Elite Pharmaceuticals's short interest ratio.

Is Elite Pharmaceuticals' short interest increasing or decreasing?

Elite Pharmaceuticals saw a decline in short interest in the month of October. As of October 15th, there was short interest totaling 2,004,100 shares, a decline of 1.6% from the previous total of 2,036,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Elite Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Elite Pharmaceuticals: Twist Bioscience Co. (15.07%), Catalyst Pharmaceuticals, Inc. (5.82%), Arrowhead Pharmaceuticals, Inc. (7.51%), CG Oncology, Inc. (14.81%), Amphastar Pharmaceuticals, Inc. (11.71%), ImmunityBio, Inc. (32.33%), ACADIA Pharmaceuticals Inc. (4.93%), 23andMe Holding Co. (6.72%), Scholar Rock Holding Co. (18.66%), Longboard Pharmaceuticals, Inc. (15.34%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Elite Pharmaceuticals stock?

Short selling ELTP is an investing strategy that aims to generate trading profit from Elite Pharmaceuticals as its price is falling. ELTP shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Elite Pharmaceuticals?

A short squeeze for Elite Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELTP, which in turn drives the price of the stock up even further.

How often is Elite Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELTP, twice per month. The most recent reporting period available is October, 15 2024.




This page (OTCMKTS:ELTP) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners